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Abstract
Background: Retinoid x receptor a (RXRa) is abundantly expressed in the liver and is essential for the function of other
nuclear receptors. Using chromatin immunoprecipitation sequencing and mRNA profiling data generated from wild type
and RXRa-null mouse livers, the current study identifies the bona-fide hepatic RXRa targets and biological pathways. In
addition, based on binding and motif analysis, the molecular mechanism by which RXRa regulates hepatic genes is
elucidated in a high-throughput manner.
Principal Findings: Close to 80% of hepatic expressed genes were bound by RXRa, while 16% were expressed in an RXRa-
dependent manner. Motif analysis predicted direct repeat with a spacer of one nucleotide as the most prevalent RXRa
binding site. Many of the 500 strongest binding motifs overlapped with the binding motif of specific protein 1. Biological
functional analysis of RXRa-dependent genes revealed that hepatic RXRa deficiency mainly resulted in up-regulation of
steroid and cholesterol biosynthesis-related genes and down-regulation of translation- as well as anti-apoptosis-related
genes. Furthermore, RXRa bound to many genes that encode nuclear receptors and their cofactors suggesting the central
role of RXRa in regulating nuclear receptor-mediated pathways.
Conclusions: This study establishes the relationship between RXRa DNA binding and hepatic gene expression. RXRa binds
extensively to the mouse genome. However, DNA binding does not necessarily affect the basal mRNA level. In addition to
metabolism, RXRa dictates the expression of genes that regulate RNA processing, translation, and protein folding
illustrating the novel roles of hepatic RXRa in post-transcriptional regulation.
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Introduction
Retinoid x receptor (RXR) plays a critical role in metabolism,
development, differentiation, proliferation, and cell death by
regulating gene expression [1,2]. The expression profile of RXRs
and their downstream signaling is altered in a variety of diseases
including breast cancer [3] and viral hepatitis [4]. Correspond-
ingly, RXR agonists are implicated in cancer prevention, antiviral
therapy, dermatological disease, and metabolic syndromes [2,5,6].
Mediated via RXRs (a, b, and c) and retinoic acid receptors (a, b,
and c), retinoic acid exerts its biological effects. In addition to
RARs, RXRa is crucial for many other receptors to work. The
receptors for fatty acids, oxysterols, bile acids, vitamin D, etc. form
dimers with RXRs to regulate gene transcription. RXRa is
essential for fetal morphogenesis [7]. Global RXRa knockout is
embryonically lethal and the embryos develop myocardiac
hypoplasia with reduced liver size at gestational day 12.5 [8].
RXRa is predominantly expressed in the liver [7]. Hepatocyte
RXRa knockout mice were produced to study its role in the liver
[9]. RXRa-deficient mice have compromised lipid [10], carbohy-
drate [11], xenobiotic [12], and amino acid homeostasis [13]. In
addition, hepatocyte RXRa is also implicated in liver steatosis and
inflammation as well as regeneration [14–17]. Specifically,
hepatocyte RXRa-deficient mice are more susceptible than wild
type mice to alcohol and non-alcohol-induced steatohepatitis [13–
15]. Partial hepatectomy-induced liver regeneration is also
hampered due to hepatic RXRa deficiency [16]. Liver is the
organ that stores and converts retinol to its biological active form
i.e. retinoic acid. Liver also produces binding proteins to deliver
retinoic acid to target sites. Furthermore, hepatocytes express high
level of RXRa. Thus, it is pivotal to understand the biological
function of RXRa in the liver.
The current study determines genome-wide RXRa binding in
normal mouse livers by chromatin immunoprecipitation using
specific anti-RXRa antibody followed by next generation
sequencing (ChIP-seq). In addition, microarray was performed
to identify genes that are differentially expressed in wild type and
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RXRa-null mouse livers. Combining the two datasets, we
established the relationship between hepatic RXRa-DNA binding
and RXRa-dependent gene expression. This global profiling of
RXRa binding along with gene expression not only allows us to
capture all RXRa downstream targets and pathways, but also
helps us to understand the molecular mechanism by which hepatic
RXRa regulates gene expression.
Materials and Methods
Animals and Tissues
The generation of hepatocyte RXRa-deficient mice was
described in previous publications [9,10]. The LoxP sequences
were inserted into introns flanking the fourth exon of the RXRa
gene and DNA binding domain of the gene is deleted after
crossing the floxed RXRa allele against a transgenic line in which
the cre recombinase is expressed under the control of the albumin
promoter. The mutant mice express a truncated protein that lacks
the DNA binding domain. However, the ligand binding domain
remains intact. Mouse livers were collected at 10 AM from 12-
week-old wild type (WT) and hepatocyte RXRa knockout (KO)
mice, which have C57BL/6 genetic background. Tissues were
snap frozen in liquid nitrogen and kept at 280uC for future use.
Animal protocols and procedures were approved by the Institu-
tional Animal Care and Use Committee (IACUC) at the
University of Kansas Medical Center and the University of
California, Davis.
RNA Preparation and Microarray
Total RNA was extracted using TRIzol Reagent (Invitrogen
Co., CA) and purified with the RNeasy Mini Kit (Qiagen Inc.,
CA). The quantity and quality of the total RNA were assessed by
Bioanalyzer 2100 (Agilent Technologies, CA). Complementary
DNA was made using High Capacity RNA-to-cDNA Kit (Applied
Biosystems, CA). Affymetrix chips (MOE 430A 2.0) that covered
about 14,000 mouse genes were used. Microarray (n = 3 per
group) and data processing as well as the methods used for data
validation were described in our previous publication [18]. By
Student t-test, genes differentially expressed in wild type and
RXRa-knockout mouse livers with p value less than 0.05 were
identified as RXRa-dependent genes.
Chromatin immunoprecipitation sequencing (ChIP-Seq)
and ChIP-qPCR
Frozen livers were fixed in 1% formaldehyde (pH=7) for
15 minutes before being quenched with 0.125 M glycine.
Following cell lysis, the nuclear fraction was extracted and
sonicated to produce 300–500 base-pair (bp) DNA fragments.
Genomic DNA (Input) was prepared by treating aliquots of
chromatin with RNase, proteinase K and heated for de-cross-
linking, followed by ethanol precipitation. Chromatin (30 mg) was
precleared by Dynase beads (Invitrogen Co., CA) before
incubation with a ChIP-quality anti-RXRa antibody (Santa Cruz,
CA). An antibody to IgG (Santa Cruz, CA) and RNA Pol II
(Millipore, MA) was used as negative and positive control,
respectively. Samples were incubated with prepared Dynase beads
at 4uC overnight, followed by de-crosslinking and purification.
Table 1. Comparison of RXRa Binding Sites.
Nuclear Receptor Target Gene Our data location (motif) Reported data location (motif) Reference
RARs Prcka 219 (NK) 293,265 (NR) [23]
Cyp26a1 21862 (DR5) 22 kb (DR5) [24]
RARb 2341 (DR5) 259 (DR5) [25]
FXR Nr0b2 2271 (IR1, DR3) 2320,2220 (NR) [26]
Abcb11 2220 , 250 (IR1) 2240,2140 (NR) [26]
LXR Abca1 2183 (DR3, 4) 270 (DR4) [27]
Fasn 2658 (DR4) 2660 (DR4) [28]
Pltp 22.2 (ER3) 22.6 kb (DR4) [29]
PPARs ACOX1 2286 (NK) 2550 (DR1) [30]
ALDH3A2 24.69 kb (DR1) 24.63 kb (DR1) [31]
Nfkbia 2111 (NK) $21.9 kb (DR1) [32]
PXR Cyp3a11 21.5 kb (ER1) 21.5 kb (NR) [33]
Slc01a4 210 kb (DR3, ER3) 210 kb (NR) [33]
Abcc3 3.8 kb (IR3, DR4) 3.8 kb (NR) [33]
CAR Cyp2b10 22.3 kb (DR4, ER1) 22.3 kb (NR) [34]
Abcc2 297 (NK) 2400 (ER8) [35]
VDR Spp1 2701 (DR3) 2761 (DR3) [36]
Cyp24a1 2322 (NK) 2265 (DR3) [37]
Pckra 114 kb (ER3, DR1) 127 kb (NR) [38]
TR Cyp7a1 23 kb (DR0) 23 kb (DR0, DR4) [39]
Thrsp 21375 (DR0, IR4) 21385 (NR) [40,41]
Egr 290 (IR5) 2112,277 (IR) [42]
DR, direct repeat; ER, everted repeat; Hu, human; IR, inverted repeat; kb, kilo-base pair; Ms, mouse; NK, not known NR, not reported.
doi:10.1371/journal.pone.0050013.t001
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DNA fragment library was size-selected (175–225 bp) on an
agarose gel. Amplified DNAs (DNA library) were sequenced on
the Illumina Genome Analyzer II. For ChIP-seq data validation,
DNA fragments generated based on above mentioned method
(n = 3) were quantified by real-time PCR with Power SYBRH
Green PCR Master Mix (Life Technologies Co., CA).
Data Analysis
Primary image analysis and base calling were performed using
Genome Analyzer Pipeline Software (Illumina Inc., CA). All
sequenced reads were aligned to mm9 mouse reference genome
using bowtie version 0.12.7 [19]. Only uniquely mapped reads
were included. Regions with reads enrichment were detected using
the Model-based Analysis of ChIP-Seq (MACS v 1.4.1) method
[20]. Non-specific peaks with false discovery ratio (FDR) greater
than 0.1 were eliminated by comparing them with the IgG
background. Peaks were further split by Mali Salmon’s Peak
Splitter (http://www.ebi.ac.uk/bertone/software.html) and fil-
tered by p-value of Poisson distribution lower than 1025. The
peak annotation was based on the UCSC genome NCBI/mm9
database. Relative to the transcription start site (TSS) or 39 end of
the gene, the peak locations were defined as ingene (summit
located within the coding region), promoter (22 kb,0 bp to the
TSS), downstream (0,100 kb to the 39 end), upstream (2100 kb
, 22 kb to the TSS), or intergenic (more than 100 kb away from
TSS or 39 end).
Motif and Pathway Analysis
The sequences that were 100 bp up and downstream from the
summits of the top 500 peaks, which had the highest peak scores,
Figure 1. Global analysis of ChIP-seq and microarray data. (A) Venn diagrams of RXRa-bound genes (III+IV+V), hepatic genes (I+II+III+IV), and
RXRa-dependent genes (II+III). RXRa binding location for (B) RXRa-dependent, (C) RXRa-independent hepatic expressed, and (D) non-hepatic
expressed genes. In gene: peak summit located within the coding region; Promoter: peak summit located within 22 kb ,0 bp to the transcription
start site (TSS); Upstream: peak summit located within -100 kb,22 kb to the TSS; Downstream: peak summit located within 0 bp ,100 kb to 39 end
of the gene; Intergenic: peak summit located outside the above mentioned regions. Red circle: RXRa-dependent genes; Blue circle: hepatic genes;
Yellow circle: RXRa-bound genes. I: RXRa-independent genes and lack of RXRa binding; II: RXRa-dependent genes but lack of RXRa binding; III: RXRa-
dependent genes that have RXRa binding; IV: RXRa-independent genes that have RXRa binding; V: non-hepatic genes that have RXRa binding.
doi:10.1371/journal.pone.0050013.g001
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were subjected to motif analysis using by MEME-ChIP (Multiple
EM for Motif Elicitation) [21]. Furthermore, a Hidden Markov
Model (HMM) was established based on nuclear receptor binding
sites from published work [22] and JASPAR CORE (http://
jaspar.cgb.ki.se/cgi-bin/jaspar db.pl) to predict the specific motif
information for all of the RXRa binding sites. All of the biological
function and pathway analyses were performed using the
Functional Annotation Tool in DAVID (DAVID; http://www.
david.niaid.nih.gov). Functional pathways or process with p,0.05
and Bonferroni value ,0.1 were accepted.
Statistical Analysis
For ChIP-qPCR data and microarray data, the difference
between two groups was analyzed by Student’s t test. P,0.05 was
considered statistically significant.
Results
Validation of RXRa binding sites discovered by ChIP-seq
Genes with known RXRa heterodimer response elements were
found to be bound by RXRa at similar locations in our ChIP-seq
data to what has been previously reported (Table 1). To further
validate the ChIP-seq results, RXRa binding sites with various
peak scores were randomly selected for confirmation by ChIP-
qPCR. Peak scores were used to scale the strength of RXRa
binding. The results showed 100%, 88%, and 87.5% confirmation
for peaks that had strong (peak score $200), medium (100# peak
score ,200), and weak (peak score ,100) bindings, respectively
[23–42].
Global RXRa binding and RXRa-dependent gene
expression in mouse livers
Microarray data showed that there were 9068 genes with
detectable signals (mRNA levels), which are referred to as ‘‘hepatic
genes’’. Among these, 768 were significantly up-regulated (UIK:
up-regulated in KO) and 696 genes were down-regulated (DIK:
down-regulated in KO) in the hepatocyte RXRa KO mouse
livers. Thus, 16.14% of hepatic genes (1464 out of 9068) were
expressed in an RXRa-dependent manner.
There were 109971 confident RXRa peaks detected in 14816
genes in the mouse liver. The average is 7.4 peaks per gene.
Remarkably, 79.1% (7174) of the hepatic genes were bound by
RXRa (Figure 1A), which includes 657 (85.5%) UIK and 605
(86.9%) DIK genes. However, 7642 RXRa-bound genes did not
have significant signals by microarray in either WT or RXRa KO
mouse livers and we refer to those genes as ‘‘non-hepatic genes’’.
The frequencies of promoter peaks are similar for RXRa-
dependent (12.2%) and -independent (12.6%) genes (Figure 1B
and C). RXRa binding sites occurred more frequently in promoter
(12.6% vs. 8.6%) and coding (49.4% vs. 39.4%) regions for the
hepatic than non-hepatic genes (Figure 1C and D). Conversely,
RXRa bound more frequently to the intergenic, up- and
downstream regions for the non-hepatic than the hepatic genes.
Thus, it seems that the binding location of RXRa could be a
determinant factor for the level of hepatic gene expression.
In terms of chromosomal distribution, RXRa binding occurred
more frequently on chromosome 5 and 11 (956 and 1115 RXRa
binding sites, respectively) than others (Figure 2). Notably, gene
function analysis demonstrated that 32% of RXRa-bound genes
on chromosome 5 are associated with alternative splicing, while
52% of RXRa-bound genes on chromosome 11 encode phosphor-
proteins suggesting the role of RXRa in post-transcriptional
modification. In addition, seven RXRa binding sites (peak scores
ranging170–470) were mapped on mitochondrial DNA in the
areas where genes were not identified by the UCSD Gene
Browser. 171 peaks were matched on X chromosome, while only 1
peak was noted on Y chromosome.
Motif Analysis of RXRa binding sites
Since RXRa dimerizes with multiple nuclear receptors, its
binding sites are composed of diverse binding motifs. The result
predicted by the Hidden Markov Model identified DR1 (12.5%) as
the most common motif for RXRa binding in mouse liver
Figure 2. Chromosomal distribution of RXRa peaks in RXRa-dependent genes in mouse liver. Each bar represents an RXRa binding site
on the mouse genome. UIK (green): up-regulated in RXRa KO liver; DIK (red): down-regulated in RXRa KO liver.
doi:10.1371/journal.pone.0050013.g002
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followed by DR4, inverted repeat (IR) 1, DR3, and IR3.
Furthermore, spacers 1, 3, and 4 were relatively more prevalent
than other spacers (Figure 3A). The results of the MEME-ChIP
analysis for the 500 strongest bindings demonstrated that one of
the most common motifs contains three half nuclear receptor
binding sites, which may form two overlapped DR1s (p=7.52E-6)
(Figure 3B). The other identified sequence contains a GC box that
matches to the motif of specific protein 1 (Sp1) binding site
(p=2.28E-5) (Figure 3C) [43].
Functional analysis of RXRa based on genetic profiling of
hepatocyte RXRa-deficient mouse livers
Biological functional analysis of both UIK and DIK genes
demonstrated that RXRa-dependent genes participated predom-
inantly in oxidation/reduction, lipid metabolism, generation of
precursor metabolites and energy, cofactor metabolism, carboxylic
acid biosynthesis, organic acid biosynthesis, coenzyme metabo-
lism, protein folding, electron transport chain, translation and
apoptosis. Among these, an average of 84% of the genes was
bound by RXRa (Table 2). The ratio of UIK and DIK genes in
each pathway revealed a distinct role for hepatic RXRa in
Figure 3. Motif Analyses. (A) Global profiling of RXRa binding motifs in mouse liver genome predicted by Hidden Markov Model. DR: direct repeat;
ER: everted repeat; IR: inverted repeat. (B) Out of the top 500 strongest bindings, the most common motif contains three half nuclear receptor
binding sites, which may form two overlapped DR1s sharing the middle half site. (C) The other common motif contains a GC box that matches to the
Sp1 binding site.
doi:10.1371/journal.pone.0050013.g003
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regulating lipid metabolism and apoptosis. For example, all of the
sterol and cholesterol biosynthetic-related genes and most of the
steroid and lipid biosynthetic-related genes were up-regulated in
KO mouse livers, which indicate the role of hepatic RXRa in the
metabolism of sterol and cholesterol. In the apoptosis pathway, 14
out of 20 anti-apoptotic genes were significantly down-regulated in
KO livers, whereas only 6 were up-regulated. This finding suggests
the pro-apoptotic role of hepatocyte RXRa. In addition to serving
as a transcriptional factor, RXRa has a role in regulating
translation as many translation-related genes were down-regulated
due to RXRa deficiency.
There were four UIK genes, including spleen tyrosine kinase
(Sykb), 3-hydroxy-3-methylglutaryl-Coenzyme A synthase 1
(Hmgcs1), isopentenyl-diphosphate delta isomerase (Idi1), and
NADP dependent steroid dehydrogenase-like (Nsdhl), which were
not bound by RXRa and are also involved in steroid and
cholesterol metabolism, suggesting RXRa could directly and
indirectly regulate steroid and cholesterol homeostasis (Figure 4A).
The analysis also revealed that the pyrin-related genes including
Mediterranean fever (Medv), myeloid cell nuclear differentiation
antigen (Mnda), and interferon activated genes 204 and 205
(Ifi204, Ifi205) were significantly induced due to lack of hepatic
RXRa, but they do not have RXRa binding sites (Figure 4A). In
addition, there were 25 DIK genes without RXRa binding sites,
which were functionally related to intracellular non-membrane-
bounded organelle, ribonucleoprotein complex, ribosome, trans-
lation or structural molecule activity (Figure 4B). Additionally,
biological functions of RXRa-bound genes (Table 3) and RXRa-
bound non-hepatic genes (Table 4) were analyzed. The RXRa-
bound genes were implicated extensively in metabolic process,
gene expression, protein processing, cell death, and response to
stress, which encompassed most of the functional pathways of
RXRa-dependent genes. However, the analysis of RXRa-bound
non-hepatic genes revealed the potential role of RXRa in other
tissues, such as neuron differentiation and development, cell
adhesion, motion, and morphogenesis as well as signal transduc-
tion.
The interaction between RXRa and other nuclear
receptors as well as cofactor genes
Surprisingly, many steroid and orphan nuclear receptor genes
were bound by RXRa in mouse livers (Table 5). Among these, the
mRNA levels of the retinoid acid receptor beta (Rarb), nuclear
receptor 1d1 (Nr1d1, Rev-erba), and Nr5a2 was significantly
changed due to hepatic RXRa deficiency. These findings were
validated by real-time PCR in livers (Figure 5). Notably, some
nuclear receptor cofactors, such as peroxisome proliferative
activated receptor c coactivator 1 a (Ppargc1a), b (Ppargc1b),
and nuclear receptor co-repressor 2 (Ncor2), were also bound by
RXRa and Ppargc1a and Ncor2 was also expressed in an RXRa-
dependent manner (Figure 5).
Discussion
It has been more than two decades since the cloning of RXRa.
Accumulated literature clearly indicates the importance of this
nuclear receptor in regulating liver disease processes such as
metabolic syndrome, alcoholic liver disease, chronic hepatitis C,
and liver cancer, which comprise some of the most serious
worldwide health issues today [2,4,5]. Thus, a global profiling of
the bona fide RXRa genomic binding sites has become essential in
order to illustrate the function and underlying regulatory
mechanism mediated by RXRa. Using high throughput genomic
methods and the knockout mouse model, the current study not
Table 2. Biological Functional Pathway Analysis of RXRa-dependent Genes.
Gene Numbers
Biological Processes* (Gene Number) RXRa-Bound (%) UIK# DIK# p value Bonferroni
oxidation reduction (120) 109 (90.8) 65 55 1.50E-18 4.40E-15
translation (50) 24 (48.0) 10 40 1.30E-05 3.70E-02
lipid biosynthetic process (48) 42 (87.5) 32 16 5.40E-07 1.60E-03
generation of precursor metabolites and energy (47) 40 (85.1) 27 20 9.70E-08 2.80E-04
fatty acid metabolic process (41) 39 (95.1) 19 22 1.50E-09 4.40E-06
steroid metabolic process (36) 31 (86.1) 26 10 1.60E-08 4.70E-05
cofactor metabolic process (36) 33 (91.7) 20 16 3.90E-07 1.10E-03
carboxylic acid biosynthetic process (29) 28 (96.6) 18 11 2.90E-06 8.50E-03
organic acid biosynthetic process (29) 28 (96.6) 18 11 2.90E-06 8.50E-03
coenzyme metabolic process (29) 29 (100) 17 12 3.90E-06 1.10E-02
protein folding (26) 15 (57.7) 10 16 1.20E-05 3.30E-02
electron transport chain (24) 21 (87.5) 14 10 1.20E-05 3.50E-02
steroid biosynthetic process (22) 17 (77.3) 17 5 4.80E-08 1.40E-04
sterol metabolic process (22) 18 (81.8) 18 4 2.20E-07 6.50E-04
anti-apoptosis (20) 18 (90.0) 6 14 3.30E-05 9.30E-02
cholesterol metabolic process (19) 15 (78.9) 15 4 4.10E-06 1.20E-02
sterol biosynthetic process (14) 10 (71.4) 14 0 1.10E-07 3.30E-04
cholesterol biosynthetic process (11) 7 (63.6) 11 0 3.30E-06 9.50E-03
*Biological processes were obtained from DAVID functional annotation.
# UIK: up-regulated gene in RXRa KO mouse liver; DIK: down-regulated gene in RXRa KO mouse liver.
doi:10.1371/journal.pone.0050013.t002
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only identifies the in vivo interaction of RXRa and the mouse
genome, but also establishes the relationship between binding and
hepatic gene expression as well as biological pathways. The
hepatocyte RXRa-deficient mice were generated by deleting the
DNA binding domain of the RXRa [9]. Thus, the differential
gene expression between WT and KO mouse livers is due to lack
of direct DNA binding of RXRa. Our data indicated that RXRa
bound 78.7% of hepatic expressed genes and more than 80% of
RXRa-dependent genes revealing the direct extensive role of
RXRa in regulating liver gene expression and liver function.
Additionally, 202 RXRa-binding free genes also displayed an
RXRa-dependent expression pattern. These genes could be
regulated by RXRa indirectly or post-transcriptionally. Moreover,
RXRa binding sites were located in all of the mouse chromosomes
as well as the mitochondrial DNA. However, the enriched
bindings on chromosome 5 and 11 and rare bindings on Y
Figure 4. Representative heat maps of functional annotation clustering of RXRa-dependent genes without RXRa binding sites.
Genes up-regulated (A) or down-regulated (B) due to hepatic RXRa deficiency were subjected to DAVID functional annotation. The gene-term
association relationship was generated using the functional annotation clustering tool in the DAVID website. Gray areas indicate the gene-term
associations have been established by the literatures. Black areas show the gene-term relationships can exist, but requires experimental validation.
Explanation for some of the listed terms shown in A: Domain: HIN-200 is a domain of HIN-200 protein, PIRSF018550 is a protein of PIR super family
with serial number of 018550, IPR004021 is a domain of protein HIN-200/IF120x. Domain: DAPIN is a domain for apoptosis and interferon response.
IPR004020: Pyrin is a subclass of DAPIN domain that interacts with proteins that have pyrin domain.
doi:10.1371/journal.pone.0050013.g004
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chromosome suggest specific biological functions of RXRa. The
current study also presented evidence for the potential role of
RXRa in regulating mitochondrial gene function. Since mito-
chondria DNA is maternally derived, the finding is congruent with
the specific binding of RXRa to the X chromosome. These
observations suggest a gender-specific effect of RXRa. Taken
together; the data indicate the extensive biological action of
endogenous RXRa ligands such as retinoic acid and fatty acids in
the liver. RXR has three isoforms. Among them, RXRa has the
highest expression level in the liver. It would be important to study
the differential and redundant role of RXRb and c using the same
approach.
Promoter and enhancer regions are regarded as the most
important regulatory regions in the control of transcription [44].
Comparing the distribution of RXRa binding sites in non-hepatic,
hepatic, and RXRa-dependent genes, RXRa bindings occurred
more frequently within the coding and promoter regions for
hepatic than non-hepatic genes. However, the distribution profile
of RXRa binding was similar between RXRa-dependent and -
independent genes. Thus, it seems like direct binding of RXRa
does not necessarily affect baseline mRNA levels. There are
several potential reasons for this. Firstly, the effect of RXRs might
be redundant and the presence of RXRb and c in hepatocyte
RXRa-deficient mouse liver may be sufficient to maintain the
basal transcriptional machinery of the hepatic RXR target genes.
Secondly, albumin-cre recombinase was used to produce the
RXRa knockout mice. Since albumin is predominantly expressed
in the hepatocyte, it is also possible that some of those RXRa-
bound genes are predominantly expressed in other types of liver
cells rather than hepatocytes. Thus, RXRa deficiency does not
alter the hepatic mRNA level. Thirdly, RXRa binding can be
‘‘silent’’. Active gene transcription occurs upon ligand binding,
which leads to recruitment of many other factors and Pol II. It is
possible that the biological level of RXRa ligands is not sufficient
to induce gene transactivation and thus knockout RXRa has no
impact on basal mRNA level. Additional experiments that use
pharmacological ligands such as retinoic acids and polyunsaturat-
ed fatty acids to activate RXRa are needed to identify exogenous
ligand/RXRa-dependent genes. The expression of gene is tissue
specific. Figure 1A shows that there are 7642 genes have RXRa
Table 3. Biological Functional Analysis of RXRa-bound Genes.
David Biological Functional Annotation Number of gene (%) p value Bonferroni
regulation of transcription 1605 (11.8) 3.20E-14 1.90E-10
Transcription 1329 (9.8) 7.70E-22 4.70E-18
intracellular signaling cascade 729 (5.4) 2.80E-23 1.70E-19
phosphate metabolic process 696 (5.1) 3.90E-24 2.30E-20
phosphorus metabolic process 696 (5.1) 3.90E-24 2.30E-20
protein localization 613 (4.5) 6.40E-24 3.90E-20
phosphorylation 575 (4.2) 2.20E-19 1.30E-15
oxidation reduction 559 (4.1) 3.00E-26 1.80E-22
establishment of protein localization 531 (3.9) 8.90E-20 5.40E-16
protein transport 527 (3.9) 1.20E-19 7.20E-16
protein amino acid phosphorylation 514 (3.8) 7.10E-18 4.30E-14
macromolecule catabolic process 504 (3.7) 1.80E-11 1.10E-07
positive regulation of macromolecule metabolic process 497 (3.7) 1.00E-13 6.10E-10
regulation of transcription from RNA polymerase II promoter 478 (3.5) 9.70E-12 5.80E-08
positive regulation of biosynthetic process 439 (3.2) 1.10E-12 6.60E-09
positive regulation of cellular biosynthetic process 436 (3.2) 7.20E-13 4.30E-09
protein catabolic process 436 (3.2) 5.40E-12 3.30E-08
positive regulation of macromolecule biosynthetic process 423 (3.1) 8.30E-14 5.00E-10
positive regulation of nitrogen compound metabolic process 418 (3.1) 4.10E-13 2.50E-09
positive regulation of nucleobase, nucleoside, nucleotide and nucleic acid
metabolic process
407 (3.0) 2.70E-13 1.60E-09
negative regulation of macromolecule metabolic process 401 (2.9) 2.70E-12 1.60E-08
cell death 398 (2.9) 3.80E-11 2.30E-07
positive regulation of gene expression 390 (2.9) 5.90E-13 3.60E-09
positive regulation of transcription 384 (2.8) 3.70E-14 2.20E-10
intracellular transport 354 (2.6) 5.00E-15 3.00E-11
cellular response to stress 325 (2.4) 1.30E-11 7.90E-08
nitrogen compound biosynthetic process 253 (1.9) 7.40E-13 4.50E-09
cellular macromolecule localization 250 (1.8) 6.90E-12 4.20E-08
cellular protein localization 248 (1.8) 1.10E-11 6.80E-08
cofactor metabolic process 161 (1.2) 1.90E-12 1.10E-08
doi:10.1371/journal.pone.0050013.t003
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binding, but mRNA levels of those genes cannot be detected in the
liver. Those genes might be expressed in the non-hepatic tissues
such as neuron and skeletal muscle. We speculate that RXRa
might have the most extensive binding in the liver genome since it
has the highest expression level in the liver. Those binding sites
may also exist in the DNA derived from other tissues.
As a master nuclear receptor, RXRa plays an essential role in
effecting the biological actions of other adopted orphan nuclear
Table 4. Biological Functional Analysis of RXRa-bound non-Hepatic Genes.
David Biological Functional Annotation Number of gene (%) p value Bonferroni
regulation of transcription 703 (10.8) 2.10E-07 9.00E-04
transcription 554 (8.5) 2.00E-05 0.084
regulation of RNA metabolic process 494 (7.6) 2.80E-08 1.20E-04
regulation of transcription, DNA-dependent 493 (7.6) 3.60E-09 1.60E-05
ion transport 253 (3.9) 3.50E-07 0.002
cell adhesion 198 (3.0) 1.20E-05 0.052
biological adhesion 198 (3.0) 1.40E-05 0.059
metal ion transport 166 (2.5) 1.10E-06 0.005
neuron differentiation 163 (2.5) 2.10E-09 9.00E-06
cell motion 138 (2.1) 9.00E-06 0.039
cell-cell signaling 120 (1.8) 1.40E-07 6.30E-04
neuron development 117 (1.8) 1.50E-06 0.006
regulation of small GTPase mediated signal transduction 101 (1.5) 3.00E-08 1.30E-04
cell part morphogenesis 87 (1.3) 1.30E-05 0.054
cell projection morphogenesis 86 (1.3) 2.60E-06 0.011
regulation of Ras protein signal transduction 77 (1.2) 9.30E-06 0.04
cell morphogenesis involved in neuron differentiation 77 (1.2) 1.20E-05 0.051
synaptic transmission 76 (1.2) 9.20E-06 0.04
neuron projection morphogenesis 74 (1.1) 2.30E-05 0.096
axonogenesis 70 (1.1) 1.70E-05 0.072
axon guidance 50 (0.8) 1.10E-06 0.005
spinal cord development 27 (0.4) 2.40E-05 0.099
doi:10.1371/journal.pone.0050013.t004
Table 5. Nuclear Receptor and Cofactor Genes that Bound by RXRa.
Endocrine receptors Orphan nuclear receptors Nuclear
Receptor cofactors
Ar Hnf1a Rara Nr1d1 (Rev-erba)* Ppargc1a*
Nr3c1 (Gr) Hnf1b Rarb* Nr1d2(Rev-erbb) Ppargc1b
Nr3c2 (Mr) Hnf4a Rarg Nr2c1 (Tr2) Ncor2*
Esr1 Nr1h3 (Lxr) Rxra Nr2c2 (Tr4) Thrap3
Esr2 Nr1h4 (Fxra) Rxrb Nr2e3 (Pnr)
Pgr Nr1h5 (Fxrb) Rxrg Nr2f1 (COUP-TF1)
Nr1i2 (Pxr) Thra Nr2f2 (COUP-TF2)
Nr1i3 (Car) Thrb Nr2f6 (COUP-TF3)
Ppara Rora Nr4a1 (Nur77)
Ppard Rorc Nr4a3 (Nor1)
Pparg Ror1 Nr6a1 (Gcnf)
Esrra Ror2 Nr0b2 (Shp1)
Esrrb Nr5a1
Esrrg Nr5a2*
*: RXRa-dependent genes confirmed by real-time PCR.
doi:10.1371/journal.pone.0050013.t005
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receptors. Based on the ‘‘1–2–3–4–5 rule’’, RXR and its partners
preferentially bind to specific motifs composed of hexamers (A/
GGGTCA) separated by a various number of nucleotides [45].
For example, DR1 is a preferred motif for peroxisome proliferator
activator receptors (PPAR)/RXR heterodimer and RXR homo-
dimer. DR4 is the preferred binding site for liver x receptor and
thyroid hormone receptor [1,46], and IR1 is the preferred motif
for farnesoid x receptor [47]. DR3, DR4, and ER6 are usually
recognized by pregnane x receptor [48]. DR2 and 5 are the main
binding motifs for retinoic acid receptor [1,45]. Therefore, the
specific heterodimeric partners of RXRa that are involved in the
regulatory process can be predicted based on the motif. The
present data showed that DR1 was the most common motif,
followed by DR4, IR1, and DR3. According to the ‘‘1–2–3–4–5
rule’’ mentioned above, PPAR/RXRa heterodimer and RXRa
homodimer may be the dominant regulators followed by LXR,
FXR, and PXR in the liver. In agreement with this finding, a
recent study showed that 67.7% and 25.7% of RXRa binding sites
overlap with those of PPARa and LXR, respectively, in normal
mouse livers [49]. Furthermore, the finding is consistent with the
phenotype of hepatocyte RXRa-deficient mice, which have
elevated serum cholesterol and triglyceride levels [16]. In addition,
lipid, bile acid, and xenobiotic metabolism are altered when the
hepatocyte RXRa-deficient mice are challenged with exogenous
ligands for those receptors [10,12]. Notably, analysis of common
sequences of the 500 strongest RXRa peaks demonstrated that
GC box, the motif of Sp1, may be one of the most popular motifs
for RXRa binding. Consistently, it has been shown that there is a
thyroid hormone response element overlapping with the GC box
in the promoter of the epidermal growth factor receptor, where it
is bound competitively by RXR/T3R and Sp1 [42]. Furthermore,
a physical interaction between RAR/RXR and Sp1 has also been
reported and such interaction synergistically enhances the
expression of RA-induced genes in vitro [50]. Our findings suggest
the presence of extensive crosstalk between Sp1 and RXRa and
their collaborative or competitive regulatory role in regulating liver
gene transcription.
Recent studies have reported the mouse liver genome-wide
binding profile of FXR [26], PXR [33], LXR, and PPARa [49].
Comparing the RXRa ChIP-seq data from this study with others’
findings, common bindings were aligned between RXRa and its
partners (data not shown). Accordingly, biological functional
analysis of RXRa-bound genes (Table 3) encompassed almost all
its partners’ biological functions. In addition, we identified novel
pathways that are specific for RXRa, which include oxidation/
reduction, protein localization, intracellular signaling cascade,
regulation of transcription, cofactor metabolic process, cellular
response to stress, and cell death. Furthermore, novel potential of
RXRa was also unveiled by the analysis of RXRa-bound non-
hepatic genes. Based on binding and expression profiling
generated from wild type and knockout mice, this paper is the
first to establish the relationship between binding and expression
in an RXRa-dependent manner.
It is important to note that our results did not show any
significant correlation between peak score and the fold change in
mRNA level caused by RXRa deficiency. In addition, the binding
characteristic (location of the peak) is similar between UIK and
DIK genes. This finding suggests that physical interaction of
RXRa is essential, but not sufficient for predicting the subsequent
transcriptional effect.
The role of retinoids in other organs such as the eye and skin is
well known. However, retinoids are stored, processed, and
metabolized in the liver. In addition, the liver is also a retinoid
target organ and yet the action of retinoids in the liver has been
Figure 5. Expression of genes in wild type and RXRa-null livers. RNA extracted from wild type and RXRa-null livers (n = 3–4) were subjected
to real time PCR to determine the expression level of the studied genes. Data were normalized to glyceraldehyde 3-phosphate dehydrogenase
(GAPDH) mRNA level.**: p,0.05 in comparisons between two groups. Microarray experiment showed that fold change in Rarb, Nr1d1, Nr5a2, Ncor2,
and Ppargc1a mRNA levels due to hepatic RXRa deficiency was 1.8, 0.7, 0.5, 1.3, and 0.3, respectively (n = 3, p,0.05).
doi:10.1371/journal.pone.0050013.g005
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overlooked. This study, for the first time, demonstrates the
potential biological effect of endogenous ligands of RXRa in the
liver. Taken together, as an active partner of many nuclear
receptors, our reported data showed that RXRa and its
endogenous ligands control liver metabolism and function in
general.
Acknowledgments
The authors thank Dr. Stan Svojanovsky for his assistance in microarray
data processing. We also thank Zoe Raglow and Julia Wu for editing the
manuscript, and Drs. Grace Guo, Ann Thomas, and Yue Cui for sharing
with us the technique of ChIP assay and the methodology of data analysis.
Author Contributions
Conceived and designed the experiments: QZ YYW. Performed the
experiments: QZ YH HL. Analyzed the data: QZ YF YH JF. Contributed
reagents/materials/analysis tools: QZ YF YH. Wrote the paper: QZ
YYW.
References
1. De Luca LM (1991) Retinoids and their receptors in differentiation,
embryogenesis, and neoplasia. FASEB J 5: 2924–2933.
2. Shulman AI, Mangelsdorf DJ (2005) Retinoid x receptor heterodimers in the
metabolic syndrome. N Engl J Med 353: 604–615.
3. Lawrence JA, Merino MJ, Simpson JF, Manrow RE, Page DL, et al. (1998) A
high-risk lesion for invasive breast cancer, ductal carcinoma in situ, exhibits
frequent overexpression of retinoid X receptor. Cancer Epidemiol Biomarkers
Prev 7: 29–35.
4. Wu C, Gilroy R, Taylor R, Olyaee M, Abdulkarim B, et al. (2011) Alteration of
hepatic nuclear receptor-mediated signaling pathways in hepatitis C virus
patients with and without a history of alcohol drinking. Hepatology 54: 1966–
1974.
5. Qu L, Tang X (2010) Bexarotene: a promising anticancer agent. Cancer
Chemother Pharmacol 65: 201–205.
6. Magliocco MA, Pandya K, Dombrovskiy V, Christiansen L, Wong Y, et al.
(2006) A randomized, double-blind, vehicle-controlled, bilateral comparison trial
of bexarotene gel 1% versus vehicle gel in combination with narrowband UVB
phototherapy for moderate to severe psoriasis vulgaris. J Am Acad Dermatol 54:
115–118.
7. Germain P, Chambon P, Eichele G, Evans RM, Lazar MA, et al. (2006)
International Union of Pharmacology. LXIII. Retinoid X receptors. Pharmacol
Rev 58: 760–772.
8. Sucov HM, Dyson E, Gumeringer CL, Price J, Chien KR, et al. (1994) RXR
alpha mutant mice establish a genetic basis for vitamin A signaling in heart
morphogenesis. Genes Dev 8: 1007–1018.
9. Wan YJ, An D, Cai Y, Repa JJ, Hung-Po Chen T, et al. (2000) Hepatocyte-
specific mutation establishes retinoid X receptor alpha as a heterodimeric
integrator of multiple physiological processes in the liver. Mol Cell Biol 20:
4436–4444.
10. Wan YJ, Cai Y, Lungo W, Fu P, Locker J, et al. (2000) Peroxisome proliferator-
activated receptor alpha-mediated pathways are altered in hepatocyte-specific
retinoid X receptor alpha-deficient mice. J Biol Chem 275: 28285–28290.
11. Wan YJ, Han G, Cai Y, Dai T, Konishi T, et al. (2003) Hepatocyte retinoid X
receptor-alpha-deficient mice have reduced food intake, increased body weight,
and improved glucose tolerance. Endocrinology 144: 605–611.
12. Cai Y, Dai T, Ao Y, Konishi T, Chuang KH, et al. (2003) Cytochrome P450
genes are differentially expressed in female and male hepatocyte retinoid X
receptor alpha-deficient mice. Endocrinology 144: 2311–2318.
13. Wu Y, Zhang X, Bardag-Gorce F, Robel RC, Aguilo J, et al. (2004) Retinoid X
receptor alpha regulates glutathione homeostasis and xenobiotic detoxification
processes in mouse liver. Mol Pharmacol 65: 550–557.
14. Gyamfi MA, Kocsis MG, He L, Dai G, Mendy AJ, et al. (2006) The role of
retinoid X receptor alpha in regulating alcohol metabolism. J Pharmacol Exp
Ther 319: 360–368.
15. Gyamfi MA, He L, French SW, Damjanov I, Wan YJ (2008) Hepatocyte
retinoid X receptor alpha-dependent regulation of lipid homeostasis and
inflammatory cytokine expression contributes to alcohol-induced liver injury.
J Pharmacol Exp Ther 324: 443–453.
16. Gyamfi MA, Tanaka Y, He L, Klaassen CD, Wan YJ (2009) Hepatic effects of a
methionine-choline-deficient diet in hepatocyte RXRalpha-null mice. Toxicol
Appl Pharmacol 234: 166–178.
17. Yang X, Guo M, Wan YJ (2010) Deregulation of growth factor, circadian clock,
and cell cycle signaling in regenerating hepatocyte RXRalpha-deficient mouse
livers. Am J Pathol 176: 733–743.
18. Guo M, Gong L, He L, Lehman-McKeeman L, Wan YJ (2008) Hepatocyte
RXRalpha deficiency in matured and aged mice: impact on the expression of
cancer-related hepatic genes in a gender-specific manner. BMC genomics 9:
403.
19. Langmead B, Trapnell C, Pop M, Salzberg SL (2009) Ultrafast and memory-
efficient alignment of short DNA sequences to the human genome. Genome Biol
10: R25.
20. Zhang Y, Liu T, Meyer CA, Eeckhoute J, Johnson DS, et al. (2008) Model-based
Analysis of ChIP-Seq (MACS). Genome Biology 9: R137.
21. Machanick P, Bailey TL (2011) MEME-ChIP: motif analysis of large DNA
datasets. Bioinformatics 27: 1696–1697.
22. Sandelin A, Wasserman WW (2005) Prediction of nuclear hormone receptor
response elements. Mol Endocrinol 19: 595–606.
23. Desai DS, Hirai S, Karnes WE, Jr., Niles RM, Ohno S (1999) Cloning and
characterization of the murine PKC alpha promoter: identification of a retinoic
acid response element. Biochem Biophys Res Commun 263: 28–34.
24. Loudig O, Maclean GA, Dore NL, Luu L, Petkovich M (2005) Transcriptional
co-operativity between distant retinoic acid response elements in regulation of
Cyp26A1 inducibility. Biochem J 392: 241–248.
25. de The H, Vivanco-Ruiz MM, Tiollais P, Stunnenberg H, Dejean A (1990)
Identification of a retinoic acid responsive element in the retinoic acid receptor
beta gene. Nature 343: 177–180.
26. Thomas AM, Hart SN, Kong B, Fang J, Zhong XB, et al. (2010) Genome-wide
tissue-specific farnesoid X receptor binding in mouse liver and intestine.
Hepatology 51: 1410–1419.
27. Costet P, Luo Y, Wang N, Tall AR (2000) Sterol-dependent transactivation of
the ABC1 promoter by the liver X receptor/retinoid X receptor. J Biol Chem
275: 28240–28245.
28. Joseph SB, Laffitte BA, Patel PH, Watson MA, Matsukuma KE, et al. (2002)
Direct and indirect mechanisms for regulation of fatty acid synthase gene
expression by liver X receptors. J Biol Chem 277: 11019–11025.
29. Mak PA, Kast-Woelbern HR, Anisfeld AM, Edwards PA (2002) Identification of
PLTP as an LXR target gene and apoE as an FXR target gene reveals
overlapping targets for the two nuclear receptors. J Lipid Res 43: 2037–2041.
30. Dreyer C, Krey G, Keller H, Givel F, Helftenbein G, et al. (1992) Control of the
peroxisomal beta-oxidation pathway by a novel family of nuclear hormone
receptors. Cell 68: 879–887.
31. Ashibe B, Motojima K (2009) Fatty aldehyde dehydrogenase is up-regulated by
polyunsaturated fatty acid via peroxisome proliferator-activated receptor alpha
and suppresses polyunsaturated fatty acid-induced endoplasmic reticulum stress.
FEBS J 276: 6956–6970.
32. Buroker NE, Barboza J, Huang JY (2009) The IkappaBalpha gene is a
peroxisome proliferator-activated receptor cardiac target gene. FEBS J 276:
3247–3255.
33. Cui JY, Gunewardena SS, Rockwell CE, Klaassen CD (2010) ChIPing the
cistrome of PXR in mouse liver. Nucleic Acids Res 38: 7943–7963.
34. Honkakoski P, Negishi M (1997) Characterization of a phenobarbital-responsive
enhancer module in mouse P450 Cyp2b10 gene. J Biol Chem 272: 14943–
14949.
35. Kast HR, Goodwin B, Tarr PT, Jones SA, Anisfeld AM, et al. (2002) Regulation
of multidrug resistance-associated protein 2 (ABCC2) by the nuclear receptors
pregnane X receptor, farnesoid X-activated receptor, and constitutive
androstane receptor. J Biol Chem 277: 2908–2915.
36. Noda M, Vogel RL, Craig AM, Prahl J, DeLuca HF, et al. (1990) Identification
of a DNA sequence responsible for binding of the 1,25-dihydroxyvitamin D3
receptor and 1,25-dihydroxyvitamin D3 enhancement of mouse secreted
phosphoprotein 1 (SPP-1 or osteopontin) gene expression. Proc Natl Acad
Sci U S A 87: 9995–9999.
37. Zierold C, Mings JA, DeLuca HF (2003) Regulation of 25-hydroxyvitamin D3-
24-hydroxylase mRNA by 1,25-dihydroxyvitamin D3 and parathyroid hor-
mone. J Cell Biochem 88: 234–237.
38. Meyer MB, Goetsch PD, Pike JW (2010) Genome-wide analysis of the VDR/
RXR cistrome in osteoblast cells provides new mechanistic insight into the
actions of the vitamin D hormone. J Steroid Biochem Mol Biol 121: 136–141.
39. Shin DJ, Plateroti M, Samarut J, Osborne TF (2006) Two uniquely arranged
thyroid hormone response elements in the far upstream 5’ flanking region confer
direct thyroid hormone regulation to the murine cholesterol 7alpha hydroxylase
gene. Nucleic Acids Res 34: 3853–3861.
40. Sudo Y, Mariash CN (1994) Two glucose-signaling pathways in S14 gene
transcription in primary hepatocytes: a common role of protein phosphorylation.
Endocrinology 134: 2532–2540.
41. Liu B, Li W, Mariash CN (1999) Two different gene elements are required for
glucose regulation of S14 transcription. Mol Cell Endocrinol 148: 11–19.
42. Xu J, Thompson KL, Shephard LB, Hudson LG, Gill GN (1993) T3 receptor
suppression of Sp1-dependent transcription from the epidermal growth factor
receptor promoter via overlapping DNA-binding sites. J Biol Chem 268: 16065–
16073.
43. Dynan WS, Tjian R (1983) The promoter-specific transcription factor Sp1 binds
to upstream sequences in the SV40 early promoter. Cell 35: 79–87.
Genome-Wide Retinoid x Receptor a Function
PLOS ONE | www.plosone.org 11 November 2012 | Volume 7 | Issue 11 | e50013
44. Levine M, Tjian R (2003) Transcription regulation and animal diversity. Nature
424: 147–151.
45. Tata JR (2002) Signalling through nuclear receptors. Nat Rev Mol Cell Biol 3:
702–710.
46. Willy PJ, Umesono K, Ong ES, Evans RM, Heyman RA, et al. (1995) LXR, a
nuclear receptor that defines a distinct retinoid response pathway. Genes Dev 9:
1033–1045.
47. Laffitte BA, Kast HR, Nguyen CM, Zavacki AM, Moore DD, et al. (2000)
Identification of the DNA binding specificity and potential target genes for the
farnesoid X-activated receptor. J Biol Chem 275: 10638–10647.
48. Kliewer SA, Goodwin B, Willson TM (2002) The nuclear pregnane X receptor:
a key regulator of xenobiotic metabolism. Endocr Rev 23: 687–702.
49. Boergesen M, Pedersen TA, Gross B, van Heeringen SJ, Hagenbeek D, et al.
(2012) Genome-Wide Profiling of Liver X Receptor, Retinoid X Receptor, and
Peroxisome Proliferator-Activated Receptor alpha in Mouse Liver Reveals
Extensive Sharing of Binding Sites. Mol Cell Biol 32: 852–867.
50. Shimada J, Suzuki Y, Kim SJ, Wang PC, Matsumura M, et al. (2001)
Transactivation via RAR/RXR-Sp1 interaction: characterization of binding
between Sp1 and GC box motif. Mol Endocrinol 15: 1677–1692.
Genome-Wide Retinoid x Receptor a Function
PLOS ONE | www.plosone.org 12 November 2012 | Volume 7 | Issue 11 | e50013
